Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has dropped 3.3%, driven by a pullback from Regeneron Pharmaceuticals of 8.8%. In the past year, the industry has gained 19%. As for the next few years, earnings are expected to grow by 28% per annum.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 25 Sep 2024 | US$898.3b | US$113.2b | -US$35,988,802,771.93 | 21.3x | -25x | 7.9x |
Fri, 23 Aug 2024 | US$909.8b | US$113.1b | -US$35,862,506,910.65 | 23.2x | -25.4x | 8x |
Sun, 21 Jul 2024 | US$1.2t | US$164.5b | -US$28,073,816,966.89 | 29x | -42.5x | 7.3x |
Tue, 18 Jun 2024 | US$1.2t | US$164.4b | -US$27,975,455,242.00 | 27.2x | -41.4x | 7x |
Thu, 16 May 2024 | US$1.1t | US$164.7b | -US$27,078,015,634.20 | 27.4x | -41.8x | 6.9x |
Sat, 13 Apr 2024 | US$1.1t | US$164.3b | -US$23,403,359,856.87 | 21.1x | -48x | 6.8x |
Mon, 11 Mar 2024 | US$1.2t | US$167.3b | -US$22,140,783,177.03 | 19x | -54x | 7.1x |
Wed, 07 Feb 2024 | US$1.3t | US$196.3b | -US$18,462,068,032.85 | 18.2x | -71.9x | 6.8x |
Fri, 05 Jan 2024 | US$1.4t | US$204.8b | -US$22,497,844,900.00 | 20.7x | -63.1x | 6.9x |
Sun, 03 Dec 2023 | US$1.3t | US$204.7b | -US$22,041,230,456.00 | 19x | -57.3x | 6.2x |
Tue, 31 Oct 2023 | US$1.2t | US$206.7b | -US$15,128,771,668.00 | 16.8x | -79x | 5.8x |
Thu, 28 Sep 2023 | US$1.3t | US$207.3b | -US$12,783,837,188.00 | 17.2x | -99.3x | 6.1x |
Sat, 26 Aug 2023 | US$1.3t | US$207.6b | -US$12,451,867,612.00 | 17.5x | -102.5x | 6.1x |
Mon, 24 Jul 2023 | US$1.2t | US$186.6b | -US$16,026,393,300.00 | 12.8x | -72x | 6.2x |
Wed, 21 Jun 2023 | US$1.2t | US$186.2b | -US$16,035,932,986.00 | 12.3x | -71.9x | 6.2x |
Fri, 19 May 2023 | US$1.1t | US$186.0b | -US$15,909,132,064.00 | 13x | -71.7x | 6.1x |
Sun, 16 Apr 2023 | US$1.2t | US$198.5b | -US$3,246,996,905.00 | 14.1x | -361.6x | 5.9x |
Tue, 14 Mar 2023 | US$1.1t | US$199.5b | -US$4,680,634,660.00 | 15x | -238.6x | 5.6x |
Thu, 09 Feb 2023 | US$1.1t | US$202.5b | US$1.3b | 16.3x | 848.7x | 5.6x |
Sat, 07 Jan 2023 | US$1.2t | US$203.3b | US$1.6b | 14.7x | 735.3x | 5.8x |
Mon, 05 Dec 2022 | US$1.2t | US$202.6b | US$1.4b | 15.1x | 844.7x | 5.8x |
Wed, 02 Nov 2022 | US$1.1t | US$205.7b | US$7.3b | 14.3x | 150.3x | 5.3x |
Fri, 30 Sep 2022 | US$1.0t | US$206.1b | US$5.7b | 14.9x | 180.5x | 5x |
Sun, 28 Aug 2022 | US$1.0t | US$206.2b | US$7.3b | 15.2x | 143x | 5x |
Tue, 26 Jul 2022 | US$1.1t | US$211.4b | US$11.3b | 15.9x | 94.9x | 5.1x |
Thu, 23 Jun 2022 | US$998.5b | US$212.5b | US$11.1b | 15.1x | 90x | 4.7x |
Sat, 21 May 2022 | US$1.0t | US$212.3b | US$10.8b | 15.1x | 93.7x | 4.8x |
Mon, 18 Apr 2022 | US$1.3t | US$226.7b | US$14.7b | 18.7x | 86.8x | 5.6x |
Wed, 16 Mar 2022 | US$1.2t | US$222.1b | US$10.5b | 18.7x | 114.8x | 5.4x |
Fri, 11 Feb 2022 | US$1.3t | US$216.3b | US$6.6b | 21.6x | 192.3x | 5.8x |
Sun, 09 Jan 2022 | US$1.3t | US$212.0b | US$2.7b | 25x | 496.1x | 6.3x |
Tue, 07 Dec 2021 | US$1.4t | US$211.9b | US$3.0b | 25x | 452.5x | 6.5x |
Thu, 04 Nov 2021 | US$1.6t | US$197.4b | -US$2,845,851,825.00 | 27.1x | -550x | 7.9x |
Sat, 02 Oct 2021 | US$1.5t | US$196.3b | -US$2,483,690,789.00 | 25.1x | -602.5x | 7.6x |
-602.5x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.90% | |
Healthcare | -0.67% | |
Biotech | -3.28% | |
Biotech | -3.28% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
BGNE BeiGene | US$209.31 | 6.0% +US$1.3b | 12.8% | PS7.2x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x | |
GILD Gilead Sciences | US$83.79 | 0.9% +US$921.3m | 10.9% | PE99x | |
UTHR United Therapeutics | US$357.87 | 3.7% +US$571.7m | 55.7% | PE14.9x |